Update to coagulopathy in COVID-19: Manifestations and management
| Autor: | Keith R. McCrae, Siddharth Dugar, Simon R. Mucha, Michael Militello, John R. Bartholomew, Gretchen Sacha, Douglas Joseph |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
High rate
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Critically ill business.industry General Medicine medicine.disease 03 medical and health sciences Fibrinogen levels 0302 clinical medicine Coagulopathy medicine 030212 general & internal medicine Ultrasonography business Intensive care medicine Venous thromboembolism Thrombotic complication |
| Zdroj: | Cleveland Clinic journal of medicine. |
| ISSN: | 1939-2869 |
| Popis: | Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings of severe COVID-19-associated coagulopathy. Prophylaxis against venous thromboembolism is paramount for all hospitalized patients with COVID-19, with more aggressive prophylaxis and screening recommended for critically ill patients with D-dimer levels above 3.0 μg/mL. Point-of-care ultrasonography is the imaging method of choice for patients at high risk, as it entails minimal risk of exposing providers to the virus. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|